The STAT1/HMGB1/NF-κB pathway in chronic inflammation and kidney injury after cisplatin exposure

Rationale: Cisplatin, a potent chemotherapeutic drug, induces side effects in normal tissues including the kidney. To reduce the side effects, repeated low-dose cisplatin (RLDC) is commonly used in clinical setting. While RLDC reduces acute nephrotoxicity to certain extents, a significant portion of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Ying, Xiang, Yu, Wang, Ying, Liu, Zhiwen, Yang, Danyi, Zha, Jie, Tang, Chengyuan, Cai, Juan, Chen, Guochun, Dong, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240827/
https://www.ncbi.nlm.nih.gov/pubmed/37284446
http://dx.doi.org/10.7150/thno.81406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240827/
https://www.ncbi.nlm.nih.gov/pubmed/37284446
http://dx.doi.org/10.7150/thno.81406

Ejemplares similares